Evidence map›Paper›PMID 41395431›Full record

ArticleHeliyon2025

Retraction notice to "Evaluation of fluorinated phospholipid analogs: A study on ADMET profiles, molecular docking and dynamics simulation in anticancer therapy" [Heliyon 11 (2025) e41739].

Saqib Ishaq, Obaid Habib, Abdul Aziz, Raheel Tahir, Hira Mushtaq, Said Hassan, Sarah Sarwar, Mohammad S Mubarak, Ajaz Ahmad, Amin Ullah

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Saqib IshaqGuangdong Provincial Key Laboratory of System Biology and Synthetics Biology for Urogenital Tumors, School of Basic Medicine, Shenzhen University Medical School, Shenzhen University (SZU), Guangdong, China.
Obaid HabibGuangdong Provincial Key Laboratory of System Biology and Synthetics Biology for Urogenital Tumors, School of Basic Medicine, Shenzhen University Medical School, Shenzhen University (SZU), Guangdong, China.
Abdul AzizDepartment of Computer Sciences and Bioinformatics, Khushal Khan Khattak University, Karak, Khyber Pakhtunkhwa, Pakistan.
Raheel TahirDepartment of Biotechnology and Genetic Engineering, Kohat University of Science and Technology (KUST), Kohat, KP, Pakistan.
Hira MushtaqCentre of Biotechnology and Microbiology, University of Peshawar, 25000, Peshawar, Pakistan.
Said HassanInstitute of Biotechnology and Microbiology, Bacha Khan University Charsada, 24550, Charsada, Pakistan.
Sarah SarwarDepartment of Biochemistry, Shaheed Benazir Bhutto Women University Peshawar, 25000, Peshawar, Pakistan.
Mohammad S MubarakDepartment of Chemistry, Indiana University Bloomington, 47405, Bloomington, USA.
Ajaz AhmadDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, 11451, Riyadh, Saudi Arabia.
Amin UllahDepartment of Allied Health Sciences, Molecular Biology Lab, Iqra National University (INU) Peshawar, 25000, Peshawar, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1016/j.heliyon.2025.e41739.].

Identifiers

PMID41395431
PMCPMC12675018

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.